Procalcitonin as an Alternative Tumor Marker of Medullary Thyroid Carcinoma.

Luca M GiovanellaMaria Luisa GaroLuca CerianiGaetano PaoneAlfredo Campenni'Federica D'Aurizio

Published in: The Journal of clinical endocrinology and metabolism (2021)

The high accuracy, compounded with favorable analytical characteristics, give ProCT great potential to replace calcitonin as a new standard of care in the management of MTC.

Keyphrases

healthcare
palliative care
quality improvement
pain management
human health
liquid chromatography
affordable care act
chronic pain